Nova Patents
AT446744T

Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease

Abstract

The invention claims for treating Parkinson's disease of the myrrh preparation, which comprises a transportation of the myrrh preparation from following active substance and sections at least two active materials: The dopamine agonist and L- Doba, the monoamine oxidase inhibitor and anti-choline of the medicine and NMDA receptor antagonist, in the specific medicine; At least two kinds of the active substance are the members of different active substance set.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

36 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
10338174GermanyA
2004009136European Patent Office (EPO)W

Members36

Family members, oldest first
DocumentOfficeKind
AU2004266063A1AustraliaA1
CA2535063A1CanadaA1
WO2005018619A1World Intellectual Property Organization (WIPO)A1
DE10338174A1GermanyA1
EP1656122A1European Patent Office (EPO)A1
MXPA06001815AMexicoA
KR20060065692ARepublic of KoreaA
IL173712A0IsraelA0
RU2005141214ARussian FederationA
BRPI0412054ABrazilA
CN1832732AChinaA
ZA200509779BSouth AfricaB
US2007026054A1United States of AmericaA1
JP2007502795AJapanA
NZ545593ANew ZealandA
EP1656122B1European Patent Office (EPO)B1
AT446744TThis recordAustriaT
ATE446744T1AustriaT1
DE502004010303D1GermanyD1
PT1656122EPortugalE
SI1656122T1SloveniaT1
DK1656122T3DenmarkT3
PL1656122T3PolandT3
ES2335771T3SpainT3
AU2004266063B2AustraliaB2
RU2397757C2Russian FederationC2
IL173712AIsraelA
JP2012092127AJapanA
EP1656122B2European Patent Office (EPO)B2
DK1656122T4DenmarkT4
ES2335771T5SpainT5
SI1656122T2SloveniaT2
PL1656122T5PolandT5
CA2535063CCanadaC
US8980308B2United States of AmericaB2
JP5827114B2JapanB2